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ABSTRACT The N-terminal region in actin has been shown to interact with both myosin and troponin (Tn) during the
cross-bridge cycle and in regulation. To study the role of this region in regulation, we used yeast actin mutants with increased
and decreased numbers of acidic residues. The mutants included D24A/D25A, with Asp24 and Asp25 replaced with alanines;
DNEQ, with the substitution of Asp2 and Glu4 with their amide analogs; and 4Ac, with Glu3 and Asp4 inserted in lieu of Ser3.
In the in vitro motility assay, using reconstituted regulated thin filaments, the sliding speeds of DNEQ, D24A/D25A, and 4Ac
were similar at all pCa values. Thus, Ca2-sensitivity of the thin filaments and the inhibitory function of TnI appear to be
insensitive to changes in charge (2) at the N-terminus of actin, suggesting little, if any, role of that actin region in regulation.
A Ca2-independent conformational change in that region was detected upon troponin binding to actin-Tm via an increase
in the fluorescence of a pyrene probe attached to another yeast actin mutant that we used (Cys1).
INTRODUCTION
In Ca2-dependent regulation of the cross-bridge cycle, a
series of direct and allosteric interactions between actin,
tropomyosin (Tm), troponin (Tn), and myosin mediate the
activation of the thin filament (reviewed in Leavis and
Gergely, 1984; Zot and Potter, 1987; Farah and Reinach,
1995; Tobacman, 1996). In the three-state model proposed
by McKillop and Geeves (1993), Tm moves across F-actin
as calcium and myosin bind to, and induce conformational
changes in, the thin filament. In this scheme, the regulatory
complex equilibrates among the blocked, closed, and open
states. Structural studies (Lehman et al., 1994; Narita et al.,
2001) and kinetic measurements (McKillop and Geeves,
1993; Geeves and Lehrer, 1994) support a repositioning of
Tm on the actin filament upon Ca2 addition. The recent
higher resolution three-dimensional reconstruction of the
thin filament (Lehman et al., 2001), that also includes the
first mapping of the Tn positions on actin, is consistent with
the main tenets of the McKillop and Geeves’ three-state
regulation model.
In the muscle thin filaments, Tn binds to actin-tropomy-
osin with a stoichiometry of 1 Tn to 1 Tm to 7 actin subunits
(Ebashi et al., 1969; Potter and Gergely, 1974). In the
absence of Ca2, the Tm–Tn complex inhibits actomyosin
interactions by predominantly occupying the blocked state,
sterically restricting the access of myosin to weak-binding
sites on actin (reviewed in Lehrer and Geeves, 1998; Squire
and Morris, 1998). In this mechanism, the inhibitory func-
tion of TnI (the inhibitory subunit of Tn) is maintained
through contacts to actin and TnC (the calcium binding
subunit of Tn). Another region of TnI interacts with TnT
(tropomyosin binding subunit of Tn), relaying perhaps con-
formational changes to Tm (reviewed in Perry, 1999). Upon
Ca2-activation, Tn undergoes conformational changes that
result in a shift of Tm–Tn to the closed state, in which the
myosin weak-binding sites are exposed (Lehman et al.,
2001).
It has been hypothesized that the interaction between TnI
and actin is maintained by electrostatic contacts, and that
this mode of interaction is important in Tn-dependent reg-
ulation of actomyosin in the presence of Tm. The basis for
this hypothesis rests with the use of synthetic peptide ana-
logs of the inhibitory region of TnI, i.e., that part of the
protein which, by itself, inhibits actin-activated myosin
ATPase (Talbot and Hodges, 1981; Levine et al., 1988).
Van Eyk and Hodges (1988) identified lysine and arginine
residues on TnI that are essential for the maximal inhibition
of acto-S1 ATPase. However, other explanations for these
results are also possible.
Chemical cross-linking results (Gergely et al., 1988) and
NMR studies (Levine et al., 1988) imply a direct interaction
between actin N-terminal acidic residues and TnI. In addi-
tion, the recent electron microscopy-based reconstituted
thin actin filament model shows Tn in close contact with the
N-terminal residues 1–4 and 23–27 on actin (Lehman et al.,
2001). However, the functional importance of these inter-
actions in the regulation of actomyosin ATPase with fully
reconstituted thin filaments has never been established or
even tested. Questions about Tm and Tn binding sites on
actin can also be raised regarding the Tm-based, cooperative
and allosteric model for thin-filament regulation (Lehrer
and Geeves, 1998). The role of Tn in this model is that of an
allosteric inhibitor of S1 binding to the thin filament and
switching it into an activated form. Clearly, it is essential to
map at a high resolution the Tm and Tn contacts on actin
and determine the importance of the ionic actin–Tn inter-
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action if we are to understand the molecular basis of the
control of muscle contraction.
To this end, we used in this work yeast actin mutants with
Asp24 and Asp25 residues replaced with alanines (D24A/
D25A); with two residues substituted (Asp2 to asn and Glu4
to gln), neutralized at the N-terminus (DNEQ); or with asp
and glu in lieu of Ser3 added to the N-terminus (4Ac) in
subdomain 1 of actin (Fig. 1). These mutants have been
used previously to assess the role of actin N-terminal acidic
residues in the formation of the weak and strong binding
states with myosin subfragment-1 (Miller et al., 1996;
Wong et al., 1999). Here, we use them to evaluate the
importance of these residues on the ability of Tn, together
with Tm, to regulate the sliding of actin filaments.
MATERIALS AND METHODS
Reagents
Adenosine triphosphate (ATP), dithiothreitol (DTT), phalloidin, phenyl-
methylsulfonyl fluoride, dextrose, 2-{[tris(hydroxymethyl)methyl]amino}-
1-ethane sulfonic acid (TES), ethylene glycol-bis(-aminoethyl eth-
er)N,N,N,N-tetraacetic acid (EGTA), Tris-HCl, and -mercaptoethanol
were purchased from Sigma (St. Louis, MO). Yeast extract and tryptone
were purchased from Difco (Detroit, MI). DNase I column materials were
purchased from Worthington Biochemical Co. (Lakewood, NJ; DNase I)
and Bio-Rad (Hercules, CA; Affigel-10). The fluorescent labels rhodamine
phalloidin and N-(1-pyrene)-maleimide were purchased from Molecular
Probes (Eugene, OR).
Preparation of proteins
Actin mutants were expressed in Saccharomyces cerevisiae yeast strain
cultures (described previously in Wertman et al., 1992; Cook et al., 1993;
Hansen et al., 2000) grown at 25°C; wild-type yeast was purchased from a
commercial bakery. Yeast actins were isolated from their respective strains
using the DNase I affinity chromatography as described previously (Cook
et al., 1992). All yeast actins were used within two weeks of purification.
The concentrations of the mutant actins were determined using the Brad-
ford protein assay, and rabbit actin as a standard. Rabbit actin and myosin
were prepared from rabbit skeletal muscle according to the methods of
Spudich and Watt (1971) and Godfrey and Harrington (1970), respectively.
Myosin subfragment 1 (S1) was prepared by chymotryptic digestion,
according to the method of Weeds and Pope (1977). The concentrations of
rabbit actin and S1 were determined spectrophotometrically using extinc-
tion coefficients of 280  7.5 cm
1 and 292  11.5 cm
1 for 1% protein
solutions, respectively. Bovine cardiac Tm and bovine cardiac Tn were
generous gifts from Dr. L. Tobacman (Univ. of Iowa).
Pyrene labeling of M1C/C374A (Cys-1) actin
Following the standard protocol for yeast actin preparation, the elutant was
dialyzed overnight against G-buffer (10 mM Tris-HCl, pH 7.5; 0.2 mM
CaCl2, 0.2 mM ATP, pH 7.0) that did not contain DTT. After determining
its actin concentration, actin was incubated at room temperature for 90 min
with a 2.5 molar ratio of pyrene maleimide (dissolved in dimethyl form-
amide) and 4 mM MgCl2. The labeling reaction was quenched with 1.0
mM DTT and spun in a Beckman XT tabletop ultracentrifuge at
140,000  g for 50 min. The supernatant was discarded; the pellet was
resuspended in G-buffer, and then dialyzed overnight. After a final ultra-
centrifugation, the collected supernatant actin contained the labeled G-
actin. The degree of pyrene-modification was determined by comparing the
actin concentration (as measured by the Bradford protein assay) with the
concentration of pyrene label, which was determined using the extinction
coefficient of 22 mM1cm1 at 344 nm. The degree of labeling was
typically 100%.
Fluorescence measurements with pyrenyl
Cys-1 actin
Fluorescence emission spectra for the pyrene-labeled Cys-1 actin were
recorded at 23°C in a SPEX Fluorolog (SPEX Industries Inc., Edison, NJ)
using an excitation wavelength of 344 nm. The concentrations of actin, Tm,
and Tn were 4.0, 2.0, and 1.0 M, respectively, with equimolar amounts of
phalloidin added to stabilize the F-actin (prepolymerized with 3.0 mM
MgCl2). The buffer consisted of 45 mM TES, pH 7.5, 50 mM NaCl, 3 mM
MgCl2, 0.2 mM ATP, 0.2 mM CaCl2, and 1 mM DTT. EGTA was added
to 1.0 mM to create “Ca2” conditions. Troponin titrations of actin–Tm
were carried out Ca2 using the same conditions as above. An excitation
wavelength of 344 nm and an emission wavelength of 394 nm were used,
and the concentration of Tn was increased in increments of0.15 M until
the final 1.0 M concentration was reached.
ATPase regulation of Cys-1 yeast actin
The rates of S1 Mg-ATPase activated by regulated pyrene-labeled Cys-1
actin in the presence and absence of Ca2 were obtained as described
previously (Gerson et al., 1999), by using light scattering to monitor the
clearing time of regulated F-acto-S1 solutions. Thin filaments were recon-
stituted using bovine cardiac Tn, and bovine cardiac Tm and the pyrene-
labeled actin. The concentrations of actin, Tm, Tn, and S1 were 4.0, 2.0,
1.0, and 1.0 M, respectively. Experiments were carried out at 23°C using
a Mg-ATP concentration of 0.1 mM and either 1.0 mM EGTA or 0.2 mM
CaCl2. The time of Mg-ATP hydrolysis was monitored by measuring the
light scattering at 350 nm from the above solutions in a SPEX Fluorolog.
In vitro motility assays
The motility assays were performed as described previously (Homsher et
al., 1996). The temperature was maintained at 25°C for all assays. Heavy
FIGURE 1 Ribbon representation of the G-actin structure (Kabsch et al.,
1990) with the mutated amino acid residues in the N-terminal region
depicted in a space-filling form. Residues 1–4, light gray, have been
mutated in the individual yeast actins used in this study: Cys-1  cysteine
introduced at the N-terminus; DNEQ  Asp2 to asn and Glu4 to gln
mutations; 4Ac asp and glu inserted in lieu of Ser3. Residues 24/25, dark
gray, indicate the site where alanines have been substituted for residues
Asp24 and Asp25.
Yeast Actins in Actomyosin Regulation 2727
Biophysical Journal 83(5) 2726–2732
meromyosin (HMM) was prepared as described by Kron et al. (1991). To
remove ATP-insensitive heads, HMM was centrifuged with 0.15 mg/ml
rabbit F-actin in a solution containing 25 mMMOPS, 25 mM KCl, 1.0 mM
MgCl2, 10 mM DTT, and 4.0 mM ATP at pH 7.4 for 30 min at
130,000  g. The supernatant was applied to nitrocellulose-treated cover-
slips at an HMM concentration of 0.3 mg/ml. Sliding speeds at various
[Ca2] were measured as previously described (Homsher et al., 1992).
Briefly, a solution containing rhodamine phalloidin-labeled actin filaments
(10 nM), together with skeletal Tm and bovine cardiac Tn, each at a
concentration of 0.5 M, was applied to the coverslip. After a 1-min
incubation period, the unbound filaments were washed away with the assay
buffer at an ionic strength  50 mM (25 mM KCl, 1 mM EGTA, 2 mM
MgCl2, 10 mM DTT, and 10 mM imidazole at pH 7.4). The viscosity of the
assay buffer was enhanced with 0.2% methylcellulose. Movement was
initiated with the assay buffer containing 1.0 mM ATP and 0.1 M each of
the regulatory proteins, with an oxygen-scavenging system. Quantification
of the sliding velocities was carried out with an Expertvision system
(Motion Analysis, Santa Rosa, CA). The velocities of individual filaments
with SD of less than half of the average velocity were used for statistical
analysis (Homsher et al., 1992), and these filaments were considered to
move smoothly in the assay system. The sliding speeds at various pCa were





where y is filament speed, ymax is the maximum filament speed, pCa50 is
the pCa value at which y  0.5ymax, and n is the Hill coefficient. The data
were fitted to r2 	 0.99.
RESULTS AND DISCUSSION
Experimental considerations
The goal of this work was to test the role of the ionic
interactions between Tn and actin subdomain-1 in the reg-
ulation of thin filaments. Although previous biochemical
studies have used purified Tn subunits (and Tm), particu-
larly for mapping their binding sites on actin, such mea-
surements are open to questions regarding the physiological
significance of information derived from the partially re-
constructed filaments. For example, it is frequently difficult
to reproduce the precise stoichiometry of the actin–Tm–Tn
complex (7:1:1) when working with actin–Tm and TnI only.
Indeed, in our experiments, the binding of TnI to actin–Tm
did not saturate at 1:7 molar ratio of TnI:actin (data not
shown). In addition, other investigators have reported on
different classes of TnI binding to actin–Tm (Zhou et al.,
2000), and on experimental difficulties related to the ten-
dency of TnI to aggregate (Perry, 1999; Geeves et al.,
2000). This complicates any attempts to assess the func-
tional role of specific sites on subdomain 1 of actin in TnI
binding in partially reconstituted thin filaments. Conse-
quently, this study has been confined to measurements on
the fully reconstituted actin–Tm–Tn complexes.
The measurement of TnI binding to actin cannot be done
with a fully reconstituted actin–Tm–Tn system because it
does not allow for release of the unbound TnI into solution.
Therefore, the evaluation of proposed TnI binding to acidic
residues in the N-terminal region of actin (residues 1–4 and
24, 25) is based in this work on testing of charge deletions
or additions on thin filament regulation. If the proposed
electrostatic contacts are indeed important in the blocked
state of the thin filament (Levine et al., 1988; Van Eyk and
Hodges, 1988; Tripet et al., 1997; Lehman et al., 2001), then
charge deletion mutations in subdomain 1 of actin should
destabilize this state. This would lower the barrier for the
transition to the closed and open states (McKillop and
Geeves, 1993) and would thus increase the Ca2 sensitivity
of the regulated actin. This prediction provided the experi-
mental framework for testing the role of acidic residues in
subdomain 1 of actin in Tm/Tn-based regulation with the
help of yeast actin mutants.
Yeast actin is 87% identical (in sequence) with muscle
actin (Ng and Abelson, 1980). It activates myosin ATPase,
moves over muscle myosin in the in vitro motility assay,
and displays the same type of regulation by Tm–Tn as does
muscle actin (Gerson et al., 1999; Korman and Tobacman,
1999; Korman et al., 2000; Morris et al., 2001). Although
there are some quantitative differences in the rates of poly-
merization and nucleotide exchange between yeast and
muscle actins (Kim et al., 1996; Chen et al., 1995), neither
of these properties was pertinent to our studies. Gerson et al.
(1999) have previously used yeast actins to study calcium-
dependent regulation in the in vitro motility assays. This and
the acto-S1 ATPase regulation assays of Korman and To-
bacman (1999), Korman et al. (2000), and Yao and Ruben-
stein (2001) established yeast actin as an attractive system
for probing the mechanism of actin regulation.
The choice of regulation assay
Actin regulation by Tm–Tn can be assayed as a function of
pCa in acto-S1 ATPase activity and in vitro motility mea-
surements. In the case of yeast actin mutants used in this
work (DNEQ and D24A/D25A), which have fewer putative
sites for electrostatic interaction with TnI than the wild-type
actin (
  2), only the latter option is open. This con-
straint is due to the low activation of S1 ATPase by the
above mutants (Miller and Reisler, 1995; Miller et al.,
1996). As documented in these prior studies, the low ac-
to-S1 ATPase activities were due to the reduced weak
binding of S1 to DNEQ and D24A/D25A mutant actins. In
the in vitro motility assays, methylcellulose (a viscosity-
enhancing agent) compensates for the reduced myosin bind-
ing (in the presence of ATP) to these actin mutants by
inhibiting their diffusion away from the HMM adsorbed to
the cover glass. This restores their sliding to that of wild
type actin (Miller and Reisler, 1995; Miller et al., 1996;
Wong et al., 1999; Doyle and Reisler, 2002), enabling the
testing of their regulation by Tm–Tn. The sliding speeds of
actin filaments in such assays are not tightly coupled to the
Vmax of actomyosin ATPase. For example, rabbit skeletal
-actin and wild type and 4Ac yeast actin filaments move at
similar speeds in the motility assays despite the different
2728 Wong et al.
Biophysical Journal 83(5) 2726–2732
Vmax values of their corresponding acto-S1 ATPase activi-
ties (Cook et al., 1993; Miller et al., 1996; Doyle and
Reisler, 2002).
pCa Dependence of regulated actin sliding in the
in vitro motility assays
The in vitro motility assays were carried out in the presence
of methylcellulose and at an ionic strength of 50 mM, i.e.,
under conditions at which the mutants and wild-type actin
slide at similar speeds over myosin. Figure 2, A and B,
shows that the D24A/D25A and DNEQ actins, each with a
net decrease of two acidic residues, had sliding speeds
similar to wild type actin at all pCa values. The pCa50
values of these mutant and wild-type actin pairs were sim-
ilar to within 0.1 pCa units. The sliding speeds of the 4Ac
mutant, that has a net increase of two acidic residues, were
also similar to wild-type actin at all pCa values (Fig. 2 C),
as were the pCa50 values (7.0  0.3 and 6.8  0.1, respec-
tively). These results show that the inhibition of filament
movement by the Tn–Tm complex in this assay does not
appear to be altered by the number of charged residues (2)
in subdomain 1 of actin.
Our results do not reveal any significant destabilization of
the blocked state of the regulated thin filament, or changes
in the Ca2-sensitivity of regulation when using the DNEQ,
D24A/D25A, and 4Ac actins. Thus, charge alteration in the
putative ionic contacts between TnI and actin subdomain 1
does not affect the overall Tn-regulation of the thin fila-
ment. This apparent tolerance in the regulation of actin to
charge density changes is inconsistent with the previously
proposed binding of TnI to the N-terminal region on actin.
Thus, the N-terminal charged residues on actin play only a
small role, if any, in the TnI-mediated inhibition of acto-
myosin. For similar reasons, our results also rule out the
possibility that the acidic sites in subdomain 1 could be
involved in the binding of TnT or Tm to the blocked-state
actin. Clearly, none of the above precludes the possibility
that other electrostatic contacts may contribute to the TnI-
actin binding. The results of Bing et al. (1998) showed that
the Tm-based regulation of E93K actin from Drosophila
melanogaster was severely affected by a more drastic mu-
tational change, i.e., charge reversal.
Pyrene fluorescence of Cys-1-labeled actin
Pyrene maleimide attached to a cysteine residue introduced
at the N-terminus of actin (Cys1) was used for probing Tn
(or Tm) interactions with that region on actin. Previous
work has shown that at this position the pyrene probe is
sensitive to S1 binding and responds differently to the
weakly and strongly bound S1 states (Hansen et al., 2000).
The activation of S1 ATPase activity by the pyrenyl Cys-1
actin was similar to that by Cys-1 actin, indicating that the
FIGURE 2 Sliding speeds of reconstituted, regulated thin filaments as a
function of pCa. (A) Wild-type (E) and D24A/D25A yeast actins (). (B)
Wild-type (E) and DNEQ yeast actins (). (C) Wild-type (E) and 4Ac ()
yeast actins. The curves were determined by least-squares regression fits to
the individual data points, using a modified Hill equation (Eq. 1). In each
plot, the solid curve represents wild-type actin, and the dashed curve
represents the mutant actin. At least 100 filaments were analyzed for each
sample. Error bars represent the standard deviation of the mean values of
the smoothly moving filaments.
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modification did not alter actin function (Hansen et al.,
2000). We have verified now that pyrenyl Cys-1 actin is
fully regulated by Tm–Tn, yielding an approximately ten-
fold Ca2-induced activation of acto-S1 ATPase, as mea-
sured by the ratio of Mg-ATPase activities in the presence
of 0.2 mM Ca2 and 1.0 mM EGTA.
The spectrum of pyrenyl Cys-1 F-actin was unchanged by
addition of Tm, but the fluorescence intensity increased by
35% with the binding of Tn to actin–Tm (Fig. 3 A).
Virtually identical fluorescence enhancement was observed
in the presence and absence of Ca2 (same increase for
both, Fig. 3 A, blue and pink traces). Tn binding to actin–
Tm, but not the Ca2 activation of regulated filaments,
appears to induce conformational changes in the N-terminal
region of actin. This suggests that conformational changes
at this site are not coupled to the activation of thin filaments.
Such a result was unexpected in the context of the perceived
biding of TnI to the N-terminus of actin (Perry, 1999) and
its observed shift away from actin upon Ca2-binding to Tn
(Tao et al., 1990). To confirm the specificity of Tn binding,
the modified actin–Tm was titrated to saturation with Tn
both in the presence and absence of calcium (Fig. 3 B, f
and , respectively). The fluorescence increases plateau in
both cases at an 1:7 molar ratio of Tn to actin, regardless
of the presence or absence of Ca2.
It is tempting to speculate that the change in pyrene
fluorescence is related to the improvement of the strong
S1–actin binding in the presence of regulatory proteins,
which is also insensitive to changes in Ca2 concentration
(Korman et al., 2000). This improved recruitment of S1 may
be connected to the increase in the isometric force exerted
by myosin on regulated compared to unregulated actin
(Homsher et al., 2000), and may be the result of allosteric
changes induced in F-actin by Tm–Tn, or a direct S1 inter-
action with Tm. In the former scenario, the Ca2-insensi-
tive, Tn-induced changes in the N-terminus of actin may be
related to the allosteric transitions that improve S1 binding
to actin.
In summary, our results show that electrostatic interac-
tions of Tn (and of other components of the regulatory
complex) with the acidic residues in the N-terminal region
of actin are not essential for the regulation of actomyosin
function by Tm–Tn. This negative result is important for
ruling out the previously proposed model of TnI interaction
with actin and emphasizes the need for mapping the binding
sites for regulatory proteins on actin. Finally, the perturba-
tion of the N-terminus of actin by Tm–Tn may be related to
the effect these proteins have on the binding of S1 to actin.
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